NCT07527169 2026-04-14A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory NeuroblastomaM.D. Anderson Cancer CenterPhase 2 Not yet recruiting16 enrolled
NCT06176989 2026-04-08Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base TumorsNational Institutes of Health Clinical Center (CC)Phase 2 Recruiting40 enrolled